Search:
 
Home > AIM > Company Profiles > Norwood Immunology

Price

Market

Sector

Market Cap
2.38p (0.00p) 0.00% AIM Health Care and Related Services £5.43m
Add to company folder | Print
Articles Financial Data Charts Profile
Related Companies
FDT
 4.88p 0.00%
AMS
 32.00p -2.29% Down
AKR
 10.00p 0.00%
AOR
 180.00p 0.00%
AVG
 46.50p 0.00%
BNX
 p
CTN
 20.00p 0.00%
CUS
 0.88p 0.00%
DSY
 2.00p 0.00%
DEMG
 9.00p 2.86% Up
GTX
 41.00p 0.00%
HCEG
 0.36p 0.00%
IDH
 203.50p -0.24% Down
LID
 8.50p 0.00%
MDW
 5.12p 0.00%
BPRG
 p
NMT
 p
OSH
 p
PKL
 p
SUN
 1.00p 0.00%
MLH
 16.75p 0.00%
TSL
 p
ZIM
 p

Commentary

Focused on the rejuvenation of the immune system and the development of virosomal vaccines

Recent Articles

Norwood Immunology loses £2.3m 13/10/2005
Drug floats drying up 02/08/2004
Tech watch - by Elliott Davis 02/06/2004

Recent Announcements

Exclusive Evaluation Agreemen
 16/07/2008
Interim Results
 31/03/2008
Board Change and Update
 21/12/2007
Preliminary Results
 30/10/2007
Interim Results
 30/03/2007

Articles from the Sector

MediLink Global UK seeks China growth 14/11/2008
Celsis ‘on track’ 12/11/2008
Southern Cross completes refinancing 31/10/2008
‘Progress’ at CareTech  15/10/2008
Southern Cross still selling 09/10/2008
Assura in £80m funding 07/10/2008
Tristel 06/10/2008
Silver lining at AMS 06/10/2008
Medicsight 14/08/2008
Earnings rise at Southern Cross 11/08/2008
More

Financial History
Financial Year End 30/06/2003 30/06/2004 30/06/2005 30/06/2006 30/06/2007
Currency AUD AUD AUD AUD AUD
Turnover 0.00 0.00 0.00 0.00 0.00
Operating Profit -5.95 -8.14 -5.23 -6.67 -4.66
Pretax Profit -5.95 -8.12 -5.23 -6.71 -4.86
Earnings After Tax -5.95 -8.12 -5.23 -6.71 -4.86
Profit Available For Dividend 0.00 0.00 0.00 0.00 0.00
Ordinary Dividends 0.00 0.00 0.00 0.00 0.00
Retained Profit -5.95 -8.12 0.00 0.00 0.00
Shareholders Funds -5.76 8.79 10.15 3.14 28.89
Net Current Assets -5.76 8.79 0.00 0.00 0.00
Adjusted Earnings Per Share Undiluted 0.00 0.00 0.04 0.00 0.00
Adj Earnings Per Share 0.00 0.00 0.04 0.00 0.00
Dividend Per Share 0.00 0.00 0.00 0.00 0.00

Company Details

Address Level 1, 322 Glenferrie Road, Victoria, 3144
Telephone
Fax

Executives

Chairman Peter Hansen (0.00% holding)
Chief Executive Richard Williams (0.00% holding)
Finance Director (0.00% holding)
Non-Exec Director Jeffrey Bell (0.00% holding)

Main Shareholders

Norwood Abbey: 39.5%
OppenheimerFunds: 12.1%
Tiedemann: 10.7%

Advisers

Nominated Adviser KBC Peel Hunt
Nominated Broker KBC Peel Hunt
Solicitors Minter Ellison
Auditors Deloitte
Registrar Computershare Investor Services

Commentary

Focused on the rejuvenation of the immune system and the development of virosomal vaccines

Company Data
Code NIM
Sedol AU000A0CAN
Shares In Issue 228.241 m
Indices
Entry on AIM 30/06/2004
Interim Results Mar
Final Results Oct
Year End Jun
Accounts Due Oct
Int div payment n/a
Fin div payment n/a
Int net div per share nil
Fin net div per share nil
Probable CGT relief